This week, Penumbra announced the CE Mark and launch of three of its reperfusion catheters: RED\u2122 43, RED\u2122 72 with SENDit\u2122 Technology, and RED\u2122 78 in Europe. These technologies expand Penumbra\u2019s neurovascular offerings designed for acute ischemic stroke.<\/p>\n
\u201cI\u2019m thoroughly impressed with the currently available RED aspiration catheters\u2019 precision in navigating and removing clots,\u201d said Dr. Levansri Makalanda, Clinical Lead for Neurointervention & Consultant Neuroradiologist at Barts Health NHS Trust, London. \u201cI\u2019m eagerly anticipating the RED 43, RED 72 SENDit and RED 78, which promise to enhance both the reach and efficiency of clot extraction.\u201d<\/p>\n
Optimizing Science-Based Aspiration Thrombectomy (S-BAT), RED 43, RED 72 with SENDit Technology, and RED 78 are engineered with the latest technology in trackability and aspiration to address a wide range of large vessel occlusions. The RED catheters feature REDglide\u2122 technology, which enhances the trackability of the catheters as they navigate the challenging vasculature of the brain. Additionally, the RED catheters have a full-length PTFE liner designed to maintain their true lumen size under powerful vacuum further maximizing aspiration efficiency.<\/p>\n
\u201cPenumbra\u2019s latest innovations offer physicians more options to provide care to their patients, regardless of the clot location,\u201d said Joan Kristensen, head of the Europe, Middle East and Africa region for Penumbra, Inc. \u201cOur focus is on pioneering technology and expanding access to these innovations with a goal of advancing the delivery of patient care in Europe and improving patient outcomes.\u201d<\/p>\n
In Europe, stroke is a leading cause of death and adult disability affecting approx. 1.1 million inhabitants of Europe every year and causing 440,000 deaths1<\/sup>. With the latest CE marked devices, Penumbra provides physicians with the most expansive aspiration thrombectomy stroke portfolio on the market.<\/p>\n Important Safety Information<\/strong> <\/p>\n 1. Cardiovascular Disease Statistics 2023, Eurostat, https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=Cardiovascular_diseases_statistics#Deaths_from_cardiovascular_diseases<\/a> This week, Penumbra announced the CE Mark and launch of three of its reperfusion catheters: RED\u2122 43, RED\u2122 72 with…<\/p>\n","protected":false},"author":8,"featured_media":66222,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[334,404],"tags":[],"class_list":["post-75524","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-eu","category-health-eu-2"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.penumbrainc.com\/eu\/wp-json\/wp\/v2\/posts\/75524","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.penumbrainc.com\/eu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.penumbrainc.com\/eu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.penumbrainc.com\/eu\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.penumbrainc.com\/eu\/wp-json\/wp\/v2\/comments?post=75524"}],"version-history":[{"count":0,"href":"https:\/\/www.penumbrainc.com\/eu\/wp-json\/wp\/v2\/posts\/75524\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.penumbrainc.com\/eu\/wp-json\/wp\/v2\/media\/66222"}],"wp:attachment":[{"href":"https:\/\/www.penumbrainc.com\/eu\/wp-json\/wp\/v2\/media?parent=75524"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.penumbrainc.com\/eu\/wp-json\/wp\/v2\/categories?post=75524"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.penumbrainc.com\/eu\/wp-json\/wp\/v2\/tags?post=75524"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nAdditional information about Penumbra\u2019s products can be located on Penumbra\u2019s website at
\nhttps:\/\/www.penumbrainc.com\/eu\/products\/neuro-thrombectomy\/<\/a>. Prior to use, please refer to Instructions for Use for complete product indications, contraindications, warnings, precautions, potential adverse events and detailed instructions for use. Risk information can be found at peninc.info\/risk<\/a>.<\/p>\n
\nBurden of Stroke in Europe, https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7382540\/#R1<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"